ZANFRAMUNDO, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 1.952
AS - Asia 1.337
EU - Europa 1.126
SA - Sud America 282
AF - Africa 107
Continente sconosciuto - Info sul continente non disponibili 107
OC - Oceania 5
Totale 4.916
Nazione #
US - Stati Uniti d'America 1.870
SG - Singapore 409
CN - Cina 376
IE - Irlanda 239
DE - Germania 205
BR - Brasile 201
VN - Vietnam 168
HK - Hong Kong 163
RU - Federazione Russa 148
IT - Italia 126
FI - Finlandia 119
FR - Francia 76
ZA - Sudafrica 75
AT - Austria 62
GB - Regno Unito 59
IN - India 53
BD - Bangladesh 51
CA - Canada 47
AR - Argentina 24
IQ - Iraq 19
EC - Ecuador 18
JP - Giappone 18
MX - Messico 15
SE - Svezia 15
VE - Venezuela 13
CO - Colombia 12
MY - Malesia 12
MA - Marocco 11
PL - Polonia 11
BE - Belgio 10
NL - Olanda 10
ES - Italia 9
ID - Indonesia 9
UZ - Uzbekistan 9
SA - Arabia Saudita 8
CZ - Repubblica Ceca 7
TN - Tunisia 6
TR - Turchia 6
AU - Australia 5
CR - Costa Rica 5
NP - Nepal 5
PK - Pakistan 5
SV - El Salvador 5
UA - Ucraina 5
AZ - Azerbaigian 4
CL - Cile 4
EG - Egitto 4
MK - Macedonia 4
PE - Perù 4
PY - Paraguay 4
BY - Bielorussia 3
JO - Giordania 3
LT - Lituania 3
PH - Filippine 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BO - Bolivia 2
DK - Danimarca 2
DZ - Algeria 2
GM - Gambi 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
MU - Mauritius 2
OM - Oman 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
BT - Bhutan 1
CH - Svizzera 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
LU - Lussemburgo 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SC - Seychelles 1
Totale 4.811
Città #
San Jose 233
Dublin 231
Singapore 208
Ashburn 188
Chandler 180
Hong Kong 160
Dallas 158
Munich 135
Council Bluffs 125
Beijing 118
Helsinki 89
Los Angeles 83
Johannesburg 67
Ho Chi Minh City 63
New York 58
Lauterbourg 57
Vienna 52
Boardman 47
Shanghai 40
São Paulo 33
Hanoi 32
Santa Clara 32
Redondo Beach 26
Columbus 24
Princeton 24
Lawrence 23
Moscow 23
Medford 22
Milan 22
Turku 22
Orem 20
Pavia 20
Pune 17
Wilmington 16
Tokyo 15
Montreal 14
Nuremberg 14
Chicago 13
Phoenix 13
Haiphong 12
London 12
Atlanta 10
Baghdad 10
Buffalo 10
Falkenstein 10
Seattle 10
Warsaw 10
Brussels 9
Manchester 9
Poplar 9
San Francisco 9
Chennai 8
Houston 8
Stockholm 8
Tashkent 8
The Dalles 8
Toronto 8
Boston 7
Da Nang 7
Kuala Lumpur 7
Mexico City 7
Quito 7
Ann Arbor 6
Changsha 6
Denver 6
Dhaka 6
Düsseldorf 6
Guangzhou 6
Portsmouth 6
Zhengzhou 6
Brooklyn 5
Caracas 5
Curitiba 5
Frankfurt am Main 5
Jyväskylä 5
Las Vegas 5
Mumbai 5
Nanjing 5
Rio de Janeiro 5
Rome 5
San Salvador 5
Secaucus 5
Tianjin 5
Xi'an 5
Biên Hòa 4
Brasília 4
Hangzhou 4
Marseille 4
Ninh Bình 4
Piscataway 4
Porto Alegre 4
San José 4
Santo André 4
Tampa 4
Agadir 3
Amsterdam 3
Baku 3
Bắc Ninh 3
Cairo 3
Cali 3
Totale 3.096
Nome #
Ultrasonography in psoriatic arthritis: Which sites should we scan? 249
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 155
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 139
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 138
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine 132
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 130
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank 124
CT-guided biopsy in the differential diagnosis of Sjogren syndrome associated cystic lung disease: A case of lung nodular AL-k amyloidosis 121
A Proof-of-Concept Analysis of Plasma-Derived Exosomal microRNAs in Interstitial Pulmonary Fibrosis Secondary to Antisynthetase Syndrome 119
Pulmonary nocardiosis in a patient affected by anti-MDA5-positive amyopathic dermatomyositis under immunosuppressive therapy 113
A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies 108
Capillary leak syndrome in a patient with cancer-associated anti-transcriptional intermediary factor 1γ dermatomyositis treated with rituximab 108
Adhesive capsulitis after COVID-19 vaccine injection: a peculiar case treated with combined bursa distention and glenohumeral capsular hydrodilatation 107
Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study 106
Defining anti-synthetase syndrome: a systematic literature review 106
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 104
Thrombocytopenia in idiopathic inflammatory myopathies: a case series analysis 103
One year in review 2018: idiopathic inflammatory myopathies 102
Respiratory failure due to concomitant interstitial lung disease and diaphragmatic involvement in a patient with anti-MDA5 dermatomyositis: a case report 100
Lumbar spondylolisthesis associated with systemic sclerosis-related spinal calcinosis: an unusual clinical case 96
Evaluation of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies Through Semiquantitative and Quantitative Analysis of Lung Computed Tomography 95
Telemedicine: a useful tool but not the holy grail. Response to: 'Telemedicine will not keep us apart in the COVID-19 pandemic' by Perniola et al 94
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 93
Idiopathic inflammatory myopathies: one year in review 2021 93
Response to: 'COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases' by Lopez-Medina et al 90
Pulmonary emphysema not combined with lung fibrosis in systemic sclerosis 88
Clinical evolution of antisynthetase syndrome after SARS-CoV2 infection: a 6-month follow-up analysis 87
Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study 87
The role of multicriteria decision analysis in the development of candidate classification criteria for antisynthetase syndrome: analysis from the CLASS project 85
Response to: 'Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic' by Santos-Moreno et al 76
Patients with interstitial lung disease secondary to autoimmune diseases: How to recognize them? 75
The Antisynthetase Syndrome" 74
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis 73
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis from the CLASS project 71
Clinical and radiological features of lung disorders related to connective-tissue diseases: a pictorial essay 70
Right atrial reservoir strain as an early predictor of pulmonary hypertension development in systemic sclerosis: a single-centre pilot study 68
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 68
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 66
Heterogeneity in nomenclature and abbreviation usage for anti-synthetase syndrome: a scoping review 64
One year in review 2020: Idiopathic inflammatory myopathies 64
Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study 59
Telemedicine in rheumatology: a reliable approach beyond the pandemic 59
Pulmonary arterial hypertension in systemic lupus erythematosus: identification of risk factors and haemodynamics characteristics in a multicentre retrospective cohort 57
Rare clinical manifestations in systemic lupus erythematosus: A review on frequency and clinical presentation 57
Real life picture of the use of intravenous immunoglobulins in idiopathic inflammatory myopathies: Results of a multicentric study 57
Efficacy of anifrolumab as a first-line therapy for the treatment of thrombocytopenia in systemic lupus erythematosus: a case report 54
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry ‘SPRING’ of the Italian Society for Rheumatology 49
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey 46
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 46
Idiopathic inflammatory myopathies and COVID-19: an intriguing liaison? 45
Issues in the classification of myositis patients: an ongoing process 41
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 37
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case–control study from the Italian national multicenter “SPRING” (Systemic Sclerosis Progression InvestiGation) Registry 36
Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care? 31
First‐line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING‐SIR registry 29
Assessment of myositis specific antibodies in primary chronic arthritis: single centre prospective study 26
Gastrointestinal involvement in very early and established systemic sclerosis: insights from the SPRING-SIR national Italian registry 24
Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study 22
Menopause in systemic sclerosis: the impact on clinical presentation in a multicenter cross-sectional analysis from the National Registry of the Italian Society for Rheumatology (SPRING-SIR) 21
Prevalence and clinical relevance of digital ulcers in systemic sclerosis patients from the real-life: the experience of the SPRING Registry of the Italian Society for Rheumatology 21
The myositis landscape in clinical trials: 2025 and beyond 19
Ultrasound for assessing disease activity and structural damage in psoriatic arthritis: the UPsA scores from a multicentre study by the Italian Society of Rheumatology 14
Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry 14
Lions, sharks, antisynthetase syndrome, and other real world beasts 11
Totale 4.916
Categoria #
all - tutte 21.482
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.482


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022146 0 0 4 1 6 3 1 10 14 5 21 81
2022/2023595 52 70 14 60 38 40 3 32 256 2 17 11
2023/2024315 30 63 11 21 19 65 20 17 2 27 14 26
2024/20251.025 23 40 10 21 20 97 129 77 244 53 110 201
2025/20262.503 189 119 244 303 269 97 352 163 240 218 142 167
2026/2027230 57 139 34 0 0 0 0 0 0 0 0 0
Totale 4.916